APEX2 and cancer: siRNA-mediated APE2 knockdown leads to substantially more γ-H2AX and micronuclei in pancreatic cancer cell PANC1 under unperturbed conditions (18), suggesting that inhibiting APE2 increased DNA damage in BRCA1/2-proficient cancer cells (Figure 6A).